141 related articles for article (PubMed ID: 19755854)
1. Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma.
Pavlin D; Cemazar M; Kamensek U; Tozon N; Pogacnik A; Sersa G
Cancer Biol Ther; 2009 Nov; 8(22):2114-22. PubMed ID: 19755854
[TBL] [Abstract][Full Text] [Related]
2. Electroporation of cytokines for cancer gene therapy.
Choo AY; Shedlock DJ; Muthumani K
Cancer Biol Ther; 2009 Nov; 8(22):2123-5. PubMed ID: 19823024
[No Abstract] [Full Text] [Related]
3. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma.
Sedlar A; Kranjc S; Dolinsek T; Cemazar M; Coer A; Sersa G
BMC Cancer; 2013 Jan; 13():38. PubMed ID: 23360213
[TBL] [Abstract][Full Text] [Related]
4. Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth.
Tamura T; Nishi T; Goto T; Takeshima H; Ushio Y; Sakata T
Anticancer Res; 2003; 23(2B):1173-9. PubMed ID: 12820368
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
[TBL] [Abstract][Full Text] [Related]
6. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
7. Cancer electrogene therapy with interleukin-12.
Cemazar M; Jarm T; Sersa G
Curr Gene Ther; 2010 Aug; 10(4):300-11. PubMed ID: 20560875
[TBL] [Abstract][Full Text] [Related]
8. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.
Tanaka F; Hashimoto W; Robbins PD; Lotze MT; Tahara H
Gene Ther; 2002 Nov; 9(21):1480-6. PubMed ID: 12378411
[TBL] [Abstract][Full Text] [Related]
10. The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12.
Reay J; Gambotto A; Robbins PD
Cancer Gene Ther; 2012 Feb; 19(2):135-43. PubMed ID: 22158522
[TBL] [Abstract][Full Text] [Related]
11. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
[TBL] [Abstract][Full Text] [Related]
12. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.
Gambotto A; Tüting T; McVey DL; Kovesdi I; Tahara H; Lotze MT; Robbins PD
Cancer Gene Ther; 1999; 6(1):45-53. PubMed ID: 10078963
[TBL] [Abstract][Full Text] [Related]
13. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
14. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
15. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma.
Gao JQ; Sugita T; Kanagawa N; Iida K; Eto Y; Motomura Y; Mizuguchi H; Tsutsumi Y; Hayakawa T; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2005 Mar; 328(4):1043-50. PubMed ID: 15707983
[TBL] [Abstract][Full Text] [Related]
16. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
[TBL] [Abstract][Full Text] [Related]
17. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
[TBL] [Abstract][Full Text] [Related]
18. Electrogene therapy with interleukin-12 in canine mast cell tumors.
Pavlin D; Cemazar M; Cör A; Sersa G; Pogacnik A; Tozon N
Radiol Oncol; 2011 Mar; 45(1):31-9. PubMed ID: 22933932
[TBL] [Abstract][Full Text] [Related]
19. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
Lucas ML; Heller L; Coppola D; Heller R
Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
[TBL] [Abstract][Full Text] [Related]
20. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]